全文获取类型
收费全文 | 473篇 |
免费 | 30篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 14篇 |
妇产科学 | 4篇 |
基础医学 | 26篇 |
口腔科学 | 4篇 |
临床医学 | 24篇 |
内科学 | 55篇 |
皮肤病学 | 6篇 |
神经病学 | 7篇 |
特种医学 | 160篇 |
外科学 | 17篇 |
综合类 | 5篇 |
预防医学 | 25篇 |
眼科学 | 6篇 |
药学 | 20篇 |
肿瘤学 | 140篇 |
出版年
2023年 | 2篇 |
2022年 | 5篇 |
2021年 | 4篇 |
2020年 | 2篇 |
2018年 | 10篇 |
2017年 | 3篇 |
2016年 | 10篇 |
2015年 | 6篇 |
2014年 | 14篇 |
2013年 | 24篇 |
2012年 | 15篇 |
2011年 | 16篇 |
2010年 | 14篇 |
2009年 | 13篇 |
2008年 | 11篇 |
2007年 | 19篇 |
2006年 | 21篇 |
2005年 | 17篇 |
2004年 | 22篇 |
2003年 | 8篇 |
2002年 | 11篇 |
2001年 | 11篇 |
2000年 | 9篇 |
1999年 | 6篇 |
1998年 | 20篇 |
1997年 | 18篇 |
1996年 | 18篇 |
1995年 | 18篇 |
1994年 | 17篇 |
1993年 | 15篇 |
1991年 | 2篇 |
1990年 | 3篇 |
1989年 | 10篇 |
1988年 | 13篇 |
1987年 | 15篇 |
1986年 | 17篇 |
1985年 | 24篇 |
1984年 | 8篇 |
1983年 | 13篇 |
1982年 | 10篇 |
1981年 | 2篇 |
1980年 | 3篇 |
1978年 | 2篇 |
1977年 | 4篇 |
1976年 | 5篇 |
1975年 | 2篇 |
1966年 | 1篇 |
1963年 | 1篇 |
排序方式: 共有514条查询结果,搜索用时 15 毫秒
91.
Peter G. Shields Christine B. Ambrosone Saxon Graham Elise D. Bowman Anita M. Harrington Kari A. Gillenwater James R. Marshall John E. Vena Rosemary Laughlin Takuma Nemoto Jo L. Freudenheim 《Molecular carcinogenesis》1996,17(3):144-150
Known breast-cancer risk factors account for only part of the variability in breast-cancer incidence. Tobacco smoke is not commonly considered a breast carcinogen, but many of its constituents, such as N-nitrosamines, are carcinogenic in laboratory animal studies. Herein, we assessed a cytochrome P4502E1 (CYP2E1) genetic polymorphism (a Dral restriction enzyme site in intron 6) as a risk factor for breast cancer in both premenopausal and postmenopausal women. Because N-nitrosamines are metabolically activated by CYP2E1, the risk among women smokers was investigated. Caucasian women were enrolled in a case-control study of breast cancer between 1986 and 1991. A subset of the women (219 premenopausal and 387 postmenopausal women) consented to phlebotomy. The allelic frequencies for the premenopausal women (D allele = 0.91 and C allele = 0.09) and postmenopausal women (D allele = 0.93 and C allele = 0.07) were similar to those previously reported. There was no statistically significant association between the CYP2E1 polymorphism and breast-cancer risk for premenopausal or postmenopausal women (adjusted odds ratio (OR) = 1.04, 95% confidence interval (CI) = 0.48, 2.24, and OR = 1.01, 95% CI = 0.55, 1.84, respectively). When the women were categorized as nonsmokers versus smokers (those who smoked more than one cigarette per week for more than 1 yr), premenopausal women with one or two C alleles who had a history of smoking were found to be at increased risk (unadjusted OR = 7.00, 95% CI = 0.75, 14.53, and adjusted OR = 11.09, 95% CI = 1.51, 81.41), although the number of study subjects with those genotypes was small. The small number of study subjects with a C allele precluded meaningful classification by level of smoking, but categorizing the smokers into two groups (above and below the median) also suggested an increased risk. Premenopausal women with the DD genotype and postmenopausal women with any genotype were not at increased risk. Breast-cancer risk was not related to the CYP2E1 genotype in either premenopausal nonsmokers or smokers (adjusted OR = 0.66, 95% CI = 0.20, 2.17, and OR = 2.13, 95% CI = 0.60, 7.59, respectively) or postmenopausal nonsmokers or smokers (OR = 0.90, 95% CI = 0.34, 2.35, and OR = 1.02, 95% CI = 0.46, 2.23, respectively), although the difference in the ORs for premenopausal nonsmokers and smokers suggests an increased risk for smokers. While there are limitations to this study, particularly related to the small number of subjects with the DC and CC genotypes, the study suggests that some women may be susceptible to tobacco smoke because of a CYP2E1 polymorphism. However, these results are preliminary and must be replicated. © 1996 Wiley-Liss, Inc. 1 This article is a US Government work and, as such, is in the public domain in the United States of America. 相似文献
92.
Anthropomorphic radiologic phantoms 总被引:1,自引:0,他引:1
A technique is being developed for the design and fabrication of anthropomorphic phantoms for diagnostic x-ray imaging. Anatomic information extracted from actual patient radiographs is incorporated into the phantoms using computer image processing and computer-assisted machining methods. In this paper, the technique is described as applied to a breast phantom, and preliminary images that closely mimic human anatomy on radiographs are shown. 相似文献
93.
94.
Kathleen M. McCarty Regina M. Santella Susan E. Steck Rebecca J. Cleveland Jiyoung Ahn Christine B. Ambrosone Kari North Sharon K. Sagiv Sybil M. Eng Susan L. Teitelbaum Alfred I. Neugut Marilie D. Gammon 《Environmental health perspectives》2009,117(4):552-558
Background
Polycyclic aromatic hydrocarbons (PAHs) may increase breast cancer risk, and the association may be modified by inherited differences in deactivation of PAH intermediates by glutathione S-transferases (GSTs). Few breast cancer studies have investigated the joint effects of multiple GSTs and a PAH biomarker.Objective
We estimated the breast cancer risk associated with multiple polymorphisms in the GST gene (GSTA1, GSTM1, GSTP1, and GSTT1) and the interaction with PAH–DNA adducts and cigarette smoking.Methods
We conducted unconditional logistic regression using data from a population-based sample of women (cases/controls, respectively): GST polymorphisms were genotyped using polymerase chain reaction and matrix-assisted laser desorption/ionization time-of-flight assays (n = 926 of 916), PAH–DNA adduct blood levels were measured by competitive enzyme-linked immunosorbent assay (n = 873 of 941), and smoking status was assessed by in-person questionnaires (n = 943 of 973).Results
Odds ratios for joint effects on breast cancer risk among women with at least three variant alleles were 1.56 [95% confidence interval (CI), 1.13–2.16] for detectable PAH–DNA adducts and 0.93 (95% CI, 0.56–1.56) for no detectable adducts; corresponding odds ratios for three or more variants were 1.18 (95% CI, 0.82–1.69) for ever smokers and 1.44 (95% CI, 0.97–2.14) for never smokers. Neither interaction was statistically significant (p = 0.43 and 0.62, respectively).Conclusion
We found little statistical evidence that PAHs interacted with GSTT1, GSTM1, GSTP1, and GSTA1 polymorphisms to further increase breast cancer risk. 相似文献95.
BACKGROUND:
Obesity is associated with poorer outcomes in patients with hormone receptor‐positive breast cancers. This association is not well established for women with triple‐negative breast cancers (TNBC). In this study, the prognostic effects of body mass index on clinical outcome were evaluated in patients with TNBC.METHODS:
A retrospective study was conducted on 418 patients who were treated between July 1996 and July 2010 for TNBC. Recurrence‐free survival (RFS) and overall survival (OS) were evaluated in relation to body mass index (BMI) after controlling for clinically significant variables.RESULTS:
One hundred twenty‐four patients (29.7%) were normal/underweight (BMI ≤24.9 kg/m2), 130 patients (31.1%) were overweight (BMI from 25 to 29.9 kg/m2), and 164 patients (39.2%) were obese (BMI ≥30 kg/m2). At a median follow‐up of 37.2 months, there were 105 recurrences (25.1%) and 87 deaths (20.8%). Compared with normal/underweight patients, the multivariate hazard ratio (HR) for RFS was 0.81 (95% confidence interval [CI], 0.49‐1.34) for obese patients. Similarly, OS was not associated with BMI category; obese patients had an HR of death of 0.94 (95% CI, 0.54‐1.64) compared with normal/underweight patients. A Cox regression analysis identified the receipt of chemotherapy (HR, 0.25; 95% CI, 0.12‐0.52), ductal histology (HR, 0.49; 95% CI, 0.25‐0.97), stage III disease (HR, 3.5; 95% CI, 1.35‐9.06), and increasing tumor size (HR, 1.19; 95% CI, 1.09‐1.3) as independent prognostic factors for OS.CONCLUSIONS:
No significant relation between obesity and RFS or OS emerged in patients with TNBC after controlling for clinically significant factors. Cancer 2011;. © 2011 American Cancer Society. 相似文献96.
Stevens KN Vachon CM Lee AM Slager S Lesnick T Olswold C Fasching PA Miron P Eccles D Carpenter JE Godwin AK Ambrosone C Winqvist R Brauch H;GENICA consortium Schmidt MK Cox A Cross SS Sawyer E Hartmann A Beckmann MW Schulz-Wendtland R Ekici AB Tapper WJ Gerty SM Durcan L Graham N Hein R Nickels S Flesch-Janys D Heinz J Sinn HP Konstantopoulou I Fostira F Pectasides D Dimopoulos AM Fountzilas G Clarke CL Balleine R Olson JE Fredericksen Z Diasio RB Pathak H Ross E Weaver J Rüdiger T Försti A 《Cancer research》2011,71(19):6240-6249
Triple-negative breast cancers are an aggressive subtype of breast cancer with poor survival, but there remains little known about the etiologic factors that promote its initiation and development. Commonly inherited breast cancer risk factors identified through genome-wide association studies display heterogeneity of effect among breast cancer subtypes as defined by the status of estrogen and progesterone receptors. In the Triple Negative Breast Cancer Consortium (TNBCC), 22 common breast cancer susceptibility variants were investigated in 2,980 Caucasian women with triple-negative breast cancer and 4,978 healthy controls. We identified six single-nucleotide polymorphisms, including rs2046210 (ESR1), rs12662670 (ESR1), rs3803662 (TOX3), rs999737 (RAD51L1), rs8170 (19p13.1), and rs8100241 (19p13.1), significantly associated with the risk of triple-negative breast cancer. Together, our results provide convincing evidence of genetic susceptibility for triple-negative breast cancer. 相似文献
97.
Tang L Yao S Till C Goodman PJ Tangen CM Wu Y Kristal AR Platz EA Neuhouser ML Stanczyk FZ Reichardt JK Santella RM Hsing A Hoque A Lippman SM Thompson IM Ambrosone CB 《Carcinogenesis》2011,32(10):1500-1506
The etiology of prostate cancer remains elusive, although steroid hormones probably play a role. Considering the carcinogenic potential of estrogen metabolites as well as altered intraprostatic estrogen biosynthesis during the development of prostate cancer, we investigated associations between repeat polymorphisms of three key estrogen-related genes (CYP11A1, CYP19A1, UGT1A1) and risk of prostate cancer in the Prostate Cancer Prevention Trial (PCPT), designed to test finasteride versus placebo as a chemoprevention agent. Using data and specimens from 1154 cases and 1351 controls who were frequency matched on age, family history of prostate cancer and PCPT treatment arm, we used logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (95% CIs) separately in the placebo and finasteride arms. Among men in the placebo arm, CYP19A1 7/8 genotype carriers had a significantly higher risk of prostate cancer compared with those with the 7/7 genotype (OR = 1.70, 95% CI = 1.16-2.5), regardless of Gleason grade. This genotype was also associated with elevated serum estrogen levels. For the (TA)(n) repeat polymorphism in UGT1A1, the heterozygous short (<7 repeats)/long (≥7 repeats) genotype was significantly associated with the risk of low-grade prostate cancer (OR = 1.34, 95% CI = 1.05-1.70) compared with the short/short genotype. No significant association was found with CYP11A1. These associations were not observed among men in the finasteride arm. The results indicate that repeat polymorphisms in genes involved in estrogen biosynthesis and metabolism may influence risk of prostate cancer but that their effects may be modified by factors altering hormone metabolism, such as finasteride treatment. 相似文献
98.
99.
CB 《Best Practice Onkologie》2012,7(1):16
Die anthroposophische Misteltherapie kann etablierte onkologische Standardtherapien im Sinne einer umfassenderen und ganzheitlichen
Versorgung erg?nzen. 相似文献
100.
Cruz MT Gonçalo M Paiva A Morgado JM Figueiredo A Duarte CB Lopes MC 《Archives of dermatological research》2005,297(1):43-47
Chemokines are involved in the control of dendritic cell (DC) trafficking, which is critical for the immune response, namely
in allergic contact dermatitis (ACD). In this work, we investigated by flow cytometry the effect of the contact sensitizers
2,4-dinitrofluorobenzene (DNFB), 1,4-phenylenediamine (PPD) and nickel sulfate (NiSO4), on the surface expression of the chemokine receptors CCR6 and CXCR4 in DC. As an experimental model of a DC we used a fetal
skin-derived dendritic cell line (FSDC), which has morphological, phenotypical and functional characteristics of skin DC.
Our results show that all the skin sensitizers studied decreased the membrane expression of the chemokine receptors CCR6 and
CXCR4. In contrast, 2,4-dichloronitrobenzene (DCNB), the inactive analogue of DNFB without contact sensitizing properties,
was without effect on the surface expression of these receptors. Lipopolysaccharide (LPS), which induces the maturation of
DC, also reduced surface CCR6 and CXCR4 expression. 相似文献